Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2026-05-24 @ 9:58 AM
Study NCT ID:
NCT04461457
Status:
COMPLETED
Last Update Posted:
2020-07-08
First Post:
2020-06-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2
Sponsor:
Vastra Gotaland Region
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
001-211Astatine
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None